Doxycycline Hyclate Doxycycline HCL Doxy HCL
Wuhan hanweishi Pharmchem Co., Ltd(Hanways chempharm) is a specialized company concentrating on the R&D, production, marketing and technical service of APIs and pharmaceutical intermediates. The leading products range are APIs, Hormones, Peptides, Pharmaceutical Intermediates. Hanways main market covers more than twenties countries and areas, also we built good and long relations with many big pharmaceutical company worldwide.
Details
Doxycycline Hyclate CAS 24390-14-5
CAS |
24390-14-5 |
MF |
C22H26N2O9 |
MW |
462.45 |
EINECS |
2017-001-1 |
Appearance |
Yellow to yellow-green crystalline solid |
Product Categories |
Heterocycle-Pyridine series;Chlorinated heterocyclic series;pyridine series;Halogenated Heterocycles;Boronic Acid;Chloropyridines;Halopyridines;Pyridines;Pyridine Derivertives;compounds of pyridine |
Uses |
Mainly used for upper respiratory tract infections, tonsillitis, biliary tract infections, lymphadenitis, cellulitis, chronic bronchitis of the elderly, etc. caused by sensitive gram-positive bacteria and gram-negative bacilli. It is also used for the treatment of typhus and chiang worms. Disease, mycoplasma pneumonia, etc. It can still be used to treat cholera, but also to prevent falciparum malaria and Leptospira infection. |
Related Products
Packing & Delivery
Company Information
Wuhan hanweishi Pharmchem Co., Ltd(Hanways chempharm) is a specialized company concentrating on the R&D, production, marketing and technical service of APIs and pharmaceutical intermediates. The leading products range are APIs, Hormones, Peptides, Pharmaceutical Intermediates. Hanways main market covers more than twenties countries and areas, also we built good and long relations with many big pharmaceutical company worldwide.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View